Inhaled corticosteroids were designed to reduce the systemic complications of oral therapy in the treatment of inflammatory respiratory disorders, such as asthma. However, even inhaled corticosteroids may have systemic effects, as evidenced by reports of growth retardation in children, and the development of cataracts in adults who use inhaled corticosteroids. The effect of inhaled corticosteroids on bone mass is still uncertain. In general, the lowest possible doses of inhaled corticosteroids should be used.

Studies about Systemic Effects of Inhaled Corticosteroids